13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q3 2025. See the latest, Q2 2026 →
Reported value
$532.97B
+6.7% on the quarter before
Positions
433
32 new · 30 sold out
Top 10
37.9%
of the value
Est. gain
+$27.64B
on stocks held all quarter
Est. return
+6.0%
on those stocks since Q2 2025
Positions as of Sep 30, 2025, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 54% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2025. Striped tiles are options.
Largest buys
Since Q2 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Nvidia~$4.27BAdded · 4.5% → 5.8%+22,896,705 shares
- Eli Lilly~$3.31BAdded · 3.2% → 3.6%+4,332,008 shares
- Unitedhealth Group Inc~$2.52BAdded · 0.4% → 0.8%+7,293,009 shares
- Applied Materials~$2.11BAdded · 0.2% → 0.6%+10,305,182 shares
- Amazon~$2.10BAdded · 3.7% → 3.9%+9,583,217 shares
- Alphabet~$1.67BAdded · 1.5% → 2.3%+6,874,381 shares
- Cenovus Energy Inc~$1.35BAdded · 0.1% → 0.3%+79,345,506 shares
- Expand Energy Corporation~$1.05BAdded · 0.1% → 0.3%+9,856,576 shares
- Nextera Energy Inc~$1.02BAdded · 0.2% → 0.4%+13,560,448 shares
- Halliburton Co~$1.01BAdded · 0.2% → 0.4%+40,969,139 shares
Largest sells
Since Q2 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Meta~$6.40BCut · 4.8% → 3.3%−8,709,080 shares
- Boeing Co~$4.16BCut · 1.5% → 0.6%−19,260,499 shares
- Royal Caribbean Group~$2.14BCut · 1.6% → 1.2%−6,611,624 shares
- Micron~$1.34BCut · 0.4% → 0.3%−7,992,357 shares
- Broadcom~$1.26BCut · 5.1% → 5.4%−3,824,140 shares
- Ge Aerospace~$1.15BCut · 1.6% → 1.5%−3,828,971 shares
- Thermo Fisher Scientific Inc~$1.10BCut · 0.4% → 0.3%−2,270,997 shares
- Ansys Inc~$984.3MSold out · 0.2% → 0.0%−2,802,689 shares
- Uber~$955.3MCut · 2.2% → 2.0%−9,751,005 shares
- First Ctzns Bancshares Inc D~$914.1MCut · 0.2% → 0.0%−510,938 shares
Holdings
As of Sep 30, 2025. Changes are in shares against Jun 30, 2025, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +1.2% · price +4.1% | 7.1% | $37.63B | +$1.47B | ||||||||
| NvidiaCOM · shares +16% · price +18.1% | 5.8% | $30.86B | +$4.07B | ||||||||
| BroadcomCOM · shares −4.2% · price +19.7% | 5.4% | $28.94B | +$4.76B | ||||||||
| AmazonCOM · shares +11% · price +0.1% | 3.9% | $20.70B | +$15.2M | ||||||||
| Eli LillyCOM · shares +21% · price −2.1% | 3.6% | $19.14B | −$343.6M | ||||||||
| MetaCL A · shares −27% · price −0.5% | 3.3% | $17.44B | −$87.9M | ||||||||
| Rtx CorporationCOM · shares +1.1% · price +14.6% | 2.4% | $12.75B | +$1.61B | ||||||||
| AlphabetCAP STK CL A · shares +16% · price +37.9% | 2.3% | $12.33B | +$2.93B | ||||||||
| AppleCOM · shares +9.2% · price +24.1% | 2.2% | $11.60B | +$2.06B | ||||||||
| UberCOM · shares −8.1% · price +5.0% | 2.0% | $10.83B | +$516.6M | ||||||||
| Ge AerospaceCOM NEW · shares −13% · price +16.9% | 1.5% | $7.93B | +$1.14B | ||||||||
| Jpmorgan Chase & Co.COM · shares −2.1% · price +8.8% | 1.4% | $7.26B | +$587.3M | ||||||||
| Starbucks CorpCOM · shares +11% · price −7.7% | 1.4% | $7.23B | −$539.1M | ||||||||
| Philip Morris Intl IncCOM · shares +7.2% · price −10.9% | 1.3% | $7.06B | −$809.8M | ||||||||
| AlphabetCAP STK CL C · shares −1.1% · price +37.3% | 1.2% | $6.62B | +$1.80B | ||||||||
| OracleCOM · shares +1.2% · price +28.6% | 1.2% | $6.56B | +$1.44B | ||||||||
| Vertex Pharmaceuticals IncCOM · shares +2.8% · price −12.0% | 1.2% | $6.48B | −$862.7M | ||||||||
| Royal Caribbean GroupCOM · shares −26% · price +3.3% | 1.2% | $6.23B | +$201.1M | ||||||||
| MastercardCL A · shares +6.5% · price +1.2% | 1.1% | $5.89B | +$66.9M | ||||||||
| Abbvie IncCOM · shares −0.1% · price +24.7% | 1.1% | $5.84B | +$1.16B | ||||||||
| NetflixCOM · shares −0.6% · price −10.5% | 1.1% | $5.64B | −$659.8M | ||||||||
| Abbott LabsCOM · shares −7.2% · price −1.5% | 0.97% | $5.19B | −$80.2M | ||||||||
| Home Depot IncCOM · shares +0.3% · price +10.5% | 0.87% | $4.62B | +$438.3M | ||||||||
| Unitedhealth Group IncCOM · shares +127% · price +10.7% | 0.84% | $4.50B | +$191.6M | ||||||||
| Carrier GlobalCOM · shares +0.2% · price −18.4% | 0.84% | $4.50B | −$1.01B | ||||||||
| Total · 433 positions | 100% | $532.97B | +$27.64B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2025 to Q3 2025: 401 stocks held throughout, up $27.64B (+6.0%).
- Broadcom+$4.76B+20%
- Nvidia+$4.07B+18%
- Alphabet+$2.93B+38%
- Apple+$2.06B+24%
- Alphabet+$1.80B+37%
- Starbucks Corp−$539.1M−8%
- Netflix−$659.8M−10%
- Philip Morris Intl Inc−$809.8M−11%
- Vertex Pharmaceuticals Inc−$862.7M−12%
- Carrier Global−$1.01B−18%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |